Correction: Cannabis-based extract for managing pain in dogs with osteoarthritis: efficacy and safety assessment

Correction on: Griebeler NM, Cremonese RP, Fakih Correa YR, Pereira PRM, Rial AF, Leite E, Gonçalves MVL, Marques das Almas LR, Cardoso NB, Cezar-dos-Santos F, Toci AT, Mojoli Le-Quesne A and Nascimento FP (2025) Cannabis-based extract for managing pain in dogs with osteoarthritis: efficacy and safety assessment. Front. Pharmacol. 16:1539704. doi: 10.3389/fphar.2025.1539704 The figure captions were in the wrong order in the PDF/HTML version of this paper. Figure 1 had the caption of Figure 2 "Biochemical marker levels during the 90-day treatment period. Part I. * p < 0.05 for significant differences between cannabis oil and placebo groups. (A) p < 0.05 for significant differences between time points 0 and 30 within the placebo group. (B) p < 0.05 for significant differences between time points 0 and 30 within the cannabis oil group. (C) p < 0.05 for significant differences between time points 0 and 90 within the cannabis oil group. (D) p < 0.05 for significant differences between time points 30 and 90 within the cannabis oil group. (E) p < 0.05 for significant differences between time points 30 and 90 within the placebo group."There was also a mistake in the caption of Figure 6 as published. Figure 6 "Biochemical marker levels during the 90-day treatment period. Part II.*p < 0.05 for significant differences between cannabis oil and placebo groups. (A) p < 0.05 for significant differences between time points 0 and 30 with in the placebo group. (B) p < 0.05 for significant differences between time points 0 and 30 with in the cannabis oil group. (C) p < 0.05 for significant differences between time points 0 and 90 with in the cannabis oil group. (D) p < 0.05 for Q27 significant differences between time points 30 and 90 with in the cannabis oilgroup. (E) p < 0.05 for significant differences between time points 30 and 90 with in the placebo group."The original version of this article has been updated. (A) p < 0.05 for significant differences between time points 0 and 30 within the placebo group. (B) p < 0.05 for significant differences between time points 0 and 30 within the cannabis oil group. (C) p < 0.05 for significant differences between time points 0 and 90 within the cannabis oil group. (D) p < 0.05 for significant differences between time points 30 and 90 within the cannabis oil group.(E) p < 0.05 for significant differences between time points 30 and 90 within the placebo group.Figure 6 Biochemical marker levels during the 90-day treatment period. Part II.*p < 0.05 for significant differences between cannabis oil and placebo groups. (A) p < 0.05 for significant differences between time points 0 and 30 with in the placebo group. (B) p < 0.05 for significant differences between time points 0 and 30 with in the cannabis oil group. (C) p < 0.05 for significant differences between time points 0 and 90 with in the cannabis oil group. (D) p < 0.05 for Q27 significant differences between time points 30 and 90 with in the cannabis oilgroup. (E) p < 0.05 for significant differences between time points 30 and 90 with in the placebo group.